A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects

Clinical Pharmacology in Drug Development
Gilmour MorrisonK W Sommerville

Abstract

GW Pharmaceuticals' formulation of highly purified cannabidiol oral solution is approved in the United States for seizures associated with Lennox-Gastaut and Dravet syndromes in patients aged ≥2 years, for which clobazam, stiripentol, and valproate are commonly used antiepileptic drugs. This open-label, fixed-sequence, drug-drug interaction, healthy volunteer trial investigated the impact of cannabidiol on steady-state pharmacokinetics of clobazam (and N-desmethylclobazam), stiripentol, and valproate; the reciprocal effect of clobazam, stiripentol, and valproate on cannabidiol and its major metabolites (7-hydroxy-cannabidiol [7-OH-CBD] and 7-carboxy-cannabidiol [7-COOH-CBD]); and cannabidiol safety and tolerability when coadministered with each antiepileptic drug. Concomitant cannabidiol had little effect on clobazam exposure (maximum concentration [Cmax ] and area under the concentration-time curve [AUC], 1.2-fold), N-desmethylclobazam exposure increased (Cmax and AUC, 3.4-fold), stiripentol exposure increased slightly (Cmax , 1.3-fold; AUC, 1.6-fold), while no clinically relevant effect on valproate exposure was observed. Concomitant clobazam with cannabidiol increased 7-OH-CBD exposure (Cmax , 1.7-fold; AUC, 1.5-fold), witho...Continue Reading

Associated Clinical Trials

References

Jan 1, 1979·British Journal of Clinical Pharmacology·W RuppO Vanderbeke
Nov 1, 1981·British Journal of Clinical Pharmacology·D J GreenblattR I Shader
Jan 1, 1984·European Journal of Clinical Pharmacology·H R OchsB Verburg-Ochs
Jun 1, 1984·British Journal of Clinical Pharmacology·E PeruccaG M Frigo
Nov 1, 1983·Journal of Clinical Pharmacology·R H LevyJ A Tor
Aug 1, 1984·Epilepsia·R H LevyT A Moreland
Sep 6, 2000·Pharmacology·P J Wedlund
Oct 24, 2001·Epilepsy Research·S Arroyo, A de la Morena
Nov 27, 2002·Therapeutic Drug Monitoring·Manuela ContinAgostino Baruzzi
Nov 10, 2004·Brain & Development·Kenjiro KosakiTakao Takahashi
Jan 18, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Carole GiraudAgnès Tran
Feb 13, 2009·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Colin D Ferrie, Amit Patel
Apr 2, 2009·Neuropsychiatric Disease and Treatment·Kenou van Rijckevorsel
Apr 3, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Anna MazurJeffery H Moran
Nov 13, 2009·The Journal of Pharmacology and Experimental Therapeutics·Nicholas A JonesGary J Stephens
Aug 9, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Satoshi YamaoriKazuhito Watanabe
Jan 16, 2013·Drug Metabolism and Pharmacokinetics·Rongrong JiangKazuhito Watanabe
Feb 15, 2013·Pharmacogenetics and Genomics·Yogita Ghodke-PuranikTeri E Klein
May 3, 2014·Therapeutic Advances in Neurological Disorders·Gabriela Purcarin, Yu-Tze Ng
Jun 27, 2015·Epilepsia·Alexandra L GeffreyElizabeth A Thiele
Jan 3, 2016·Lancet Neurology·Orrin DevinskyMaria Roberta Cilio
Jun 7, 2016·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Elaine C Wirrell
May 26, 2017·The New England Journal of Medicine·Orrin DevinskyUNKNOWN Cannabidiol in Dravet Syndrome Study Group
Aug 7, 2017·Epilepsia·Tyler E GastonUNKNOWN UAB CBD Program
Nov 15, 2017·Clinical Pharmacology and Therapeutics·Andrea GaedigkUNKNOWN PharmVar Steering Committee
Mar 16, 2018·Neurology·Orrin DevinskyUNKNOWN GWPCARE1 Part A Study Group
May 17, 2018·The New England Journal of Medicine·Orrin DevinskyUNKNOWN GWPCARE3 Study Group

❮ Previous
Next ❯

Citations

Jun 19, 2019·Epilepsia·Kerstin A KlotzJulia Jacobs
Oct 17, 2019·Drugs·James E Frampton
Dec 8, 2019·International Journal of Molecular Sciences·Keith A Kwan CheungMurray D Mitchell
Oct 29, 2019·British Journal of Clinical Pharmacology·Kirsten Riber BergmannGeert Jan Groeneveld
Oct 23, 2019·The Cochrane Database of Systematic Reviews·Rebecca BresnahanAnthony G Marson

Dec 14, 2019·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Jairo Vinícius PintoLakshmi N Yatham
Apr 10, 2020·Expert Opinion on Drug Metabolism & Toxicology·Rafael G Dos SantosAntônio W Zuardi
Feb 13, 2020·Current Opinion in Neurology·Zhibin ChenPatrick Kwan
Jul 3, 2020·Epilepsia·Nancy A McNamaraRenée A Shellhaas
Jun 28, 2020·Acta Neurologica Scandinavica·Orrin DevinskyVolker Knappertz
Jun 27, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sumit BansalJashvant D Unadkat
Jan 11, 2020·Frontiers in Neurology·Kerstin A KlotzJulia Jacobs
Aug 29, 2020·BioMed Research International·Marta VázquezPaula Schaiquevich
Jun 7, 2019·The Annals of Pharmacotherapy·Marcia L Buck, Howard P Goodkin
Aug 3, 2019·Drugs·Valentina Franco, Emilio Perucca
May 29, 2020·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Katherine E HamiltonStephanie J Phelps
Apr 9, 2020·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Edward ChesneyPhilip McGuire
Apr 25, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Serena SilvestroEmanuela Mazzon
Aug 26, 2020·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Renad Abu-SawwaYong Park
Oct 8, 2020·Expert Review of Neurotherapeutics·Simona LattanziPasquale Striano
Sep 3, 2020·Pharmaceuticals·Sophie Anne MillarSaoirse Elizabeth O'Sullivan
Sep 25, 2020·Acta Neurologica Scandinavica·Boudewijn GunningDaniel Checketts
Dec 5, 2020·Expert Opinion on Drug Discovery·Barbara Miziak, Stanisław Czuczwar
Feb 10, 2021·Clinical Drug Investigation·Randi von WredeRainer Surges
Dec 30, 2020·Journal of Korean Medical Science·Chung Mo KooHoon Chul Kang
Jan 31, 2021·Journal of General Internal Medicine·Premalatha BalachandranKevin P Hill
Oct 30, 2020·Frontiers in Pharmacology·Umberto RaucciPasquale Parisi
Feb 29, 2020·Lancet Neurology·Emilio PeruccaTorbjörn Tomson
Apr 27, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Patrícia AlvesGeorgina Correia-da-Silva
Mar 23, 2021·Frontiers in Pharmacology·Manuela Contin Cbd Lice Italy Study Group
Sep 13, 2020·The International Journal on Drug Policy·Iain S McGregorNatalie Gauld

❮ Previous
Next ❯

Software Mentioned

Phoenix WinNonlin

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.